| 1 Goya T,Asamura H,Yoshimura H,et al.Prognosis of 6644 resected non-small cell lung cancers in Japan:a Japanese lung cancer registry study[J].Lung Cancer, 2005,50(2):227-234.
2 Mountain CF.Revisions in international system for staging lung cancer[J].Chest, 1997,111(6):1710-17.
3 Non-Small Cell Lung Cancer Collaborative Group.Chemotherapy in non-small cell lung cacner:a meta-analysis using updated data on individual patients from 52 randomized clinical trials[J].BMJ,1995,311(7010):899-909.
4 Scagliotti GV.Fossati R,Torri V,et al.Randomized study of adjuvant chemotherapy for completely resected stageⅠ,Ⅱ,orⅢ_A non-small -cell Lung cancer[J].J Natl Cancer Inst,2003,95(19 ):1453 -61.
5 Waller D,Peake MD,Stephens RJ.et al.Chemotherapy for patients with non-small cell lung cancer;the surgical setting of the Big Lung Trial[J].Eur J Cardiothorac Surg,2004,26(l):173-82.
6 Rudd R,Gower NH,J ames L E,et al.PhaseⅢrandomized comparison of gemcitabine and carboplatin(GC) with mitomycin,ifosfamide and cisplatin(MIP) in advanced non-small cell lung cancer(NSCLC)[J].ASCO,2002,21:292a.
7 Melo MJ,Barradas P,Costa A,et al.Result s of a randomized phaseⅢt rial comparing 4 cisplatin(P) -based regimens in the treatment of locally advanced and metastatic non-small cell lung cancer(NSCLC):mitomycin/ vinblastine/ cisplatin (MVP) is no longer a therapeutic option[J].ASCO,2002,21:302a.
8 Postoperative radiotherapy in non-small cell lung cancer:systematic review and meta -analysis of individual patient data from nine randomized controlled trials[J] .Lancet,1998,352(9124):257-63.
9 Aniagada R,Bergman B.Dunant A,et al.Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer[J],N Engl J Med, 2004,350(4):351-360.
10 Timothy W.Robert L,David J,et al.Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer[J].N Engl J Med,2005,352(25):2589-97.
11 Bezjak A,Lee CW,Ding K,et al.Quality of life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer:results from a randomized trial, JBR 10.J Clin Oncol,2008,26(31):5052-59.
12 Douillard J,Rosell R.Delena M,et al.Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stageⅠ_B -Ⅲ_A non -small cell lung cancer(Adjuvant navelbine International Trialist Association[ANITA]):a randomised controlled trial[J].Lancet Oncol,2006,7(9):719-727.
13 Pignon JP,Triboder GV,Scagliotti G,et al.Lung Adjuvant Cisplatin Evaluation (LACE):a pooled analysis of five randomized clinical trials including 4,584 patients [J].J Clin Oncol,2006,24(18 Suppl):366s(abstr.#7008).
14 Fr(u|¨)h M.Rolland E,Pignon JP.et al Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.J Clin Oncol,2008,26(21):3573-81.
15 Langer CJ.Resectable non-small cell lung cancer in the elderly:is there a role for adjuvant treatment? Drugs Aging.2008;25(3):209-18.
16 Kato H,Ichinose Y.Ohta M,et al.A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung[J],N Engl J Med,2004,350 (17):1713-21.
17 Strauss GM,Hemden J,Maddaus MA,et al.Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer(NSCLC):Report of Cancer and Leukemia Group B(CALGB) Protocol 9633[J].J Clin Oncol,2004;22:621s(abstr.#7019).
18 Strauss GM,Hernden J,Maddaus MA,et al.Adjuvant chemotherapy in Stage IB non-small cell lung cancer(NSCLC):update on Cancer and Leukemia Group B (CALGB) protocol 9633[J].J Clin Oncol,2006,24(18Suppl):365s(abstr.# 7007).
19 Strauss GM,Hemdon JE 2nd,Maddaus MA,et al.Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer;CALGB 9633 with the Cancer and Leukemia Group B,Radiation Therapy Oncology Group,and North Central Cancer Treatment Group Study Groups.J Clin Oncol, 2008,26(31):5043-51.
20 Olaussen KA.Dunant A,Fouret,et aL DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin -based adjuvant chemotherapy[J].N Engl J Med, 2006,7;355(l0):983-91. |
